The availability of private funding remains an important but elusive factor for success
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
https://doi.org/10.1038/News@Nature(10Aug2004)Bioentrepreneurship
https://doi.org/10.1038/NatureBiotechnology22,1060-1060(01Sep2004)News
Russia becomes attractive as a source of IP for biotechs
https://doi.org/10.1038/News@Nature(06Oct2005)Bioentrepreneurship
https://doi.org/10.1038/NatureBiotechnology23,1031-1031(01Sep2005)News
Rights and permissions
About this article
Cite this article
Jia, H., Jayarama, K. & Astvatsaturyan, M. Lack of private financing hobbles emerging biotech regions. Nat Biotechnol 24, 7–9 (2006). https://doi.org/10.1038/nbt0106-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0106-7
This article is cited by
-
China, Globalisation and Health Biotechnology Innovation: Venture Capital and the Adaptive State
East Asian Science, Technology and Society: an International Journal (2009)
